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Purpose: To examine the applicability of the newly developed Rivermead Behavioural Memory 
Test – Third Edition (RBMT-3) as an ecologically-valid memory test in patients with alcohol-
related cognitive disorders.
Patients and methods: An authorized Dutch translation of the RBMT-3 was developed, 
equivalent to the UK version, and administered to a total of 151 participants – 49 patients with 
amnesia due to alcoholic Korsakoff’s syndrome, 49 patients with cognitive impairment and a history 
of chronic alcoholism, not fulfilling the Korsakoff criteria, and 53 healthy controls. Between-group 
comparisons were made at subtest level, and the test’s diagnostic accuracy was determined.
Results: Korsakoff patients performed worse than controls on all RBMT-3 subtests 
(all P-values , 0.0005). The alcoholism group performed worse than controls on most (all 
P-values , 0.02), but not all RBMT-3 subtests. Largest effects were found between the Korsakoff 
patients and the controls after delayed testing. The RBMT-3 had good sensitivity and adequate 
specificity.
Conclusion: The RBMT-3 is a valid test battery to demonstrate everyday memory deficits in 
Korsakoff patients and non-Korsakoff patients with alcohol abuse disorder. Korsakoff patients 
showed an impaired performance on subtests relying on orientation, contextual memory and 
delayed testing. Our findings provide valuable information for treatment planning and adjustment 
in patients with alcohol-related cognitive impairments.
Keywords: ecological validity, neuropsychological assessment, Korsakoff’s syndrome, alcohol-
induced persisting amnestic disorder, episodic memory, treatment outcome
Introduction
Chronic alcohol abuse may result in brain damage and cognitive deficits, such as 
impairment in memory function, but also deficits in executive functions. For example, 
in Korsakoff’s syndrome, chronic thiamine deficiency may result in bilateral lesions 
of the diencephalon, including the mammillary bodies and thalamus, which may 
produce severe anterograde and (to a lesser extent) retrograde amnesia.1 Specifically, 
the episodic aspect of long-term memory is impaired in Korsakoff patients,2 like 
memory for contextual information as such (eg, spatial information or temporal-order 
memory) and the ability to associate context and target information, that is, the ‘what, 
where and when’ of everyday experiences. Milder forms of memory deficits have been 
reported in non-Korsakoff chronic alcoholics, due to the neurotoxic nature of alcohol 
that may result in global brain atrophy.3
A wide variety of neuropsychological tests is available to examine memory function 
in brain injured adults, such as the California Verbal Learning Test (CVLT), the Rey 
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Auditory Verbal Learning Test (RAVLT) and the Wechsler 
Memory Scale – Fourth edition (WMS-IV).4 However, 
many of these tests have been criticized as they may lack the 
ability to predict daily-life functioning (often referred to as 
ecological validity).5 The Rivermead Behavioural Memory 
Test (RBMT) has been specifically developed as a measure 
of everyday memory function.6 Also, parallel versions 
of the test were developed, making this memory battery 
applicable for treatment outcome assessment. The RBMT 
has been widely used for examining patients with alcohol-
related cognitive disorders, and has been recommended 
for use in Korsakoff patients given its relevance for daily 
memory problems.7 Duffy and O’Carroll,8 for instance, 
demonstrated that compared to other memory tests, the 
RBMT resulted in the largest effect sizes when comparing 
Korsakoff patients with other neuropsychiatric patients (ie, 
patients with schizophrenia). Several other studies also 
reported profound deficits in Korsakoff patients compared 
to normative data.9,10 Furthermore, the RBMT has been used 
to examine treatment effects of fluvoxamine in Korsakoff 
patients on memory function.11 The RBMT has also been 
applied in the study of non-Korsakoff alcohol users. For 
example, Van Balen et al12 have examined a heterogeneous 
group of alcohol-related cognitive disorders, showing poor 
performances on the RBMT. Others have administered the 
RBMT in long-abstinent alcoholics without KS, showing 
an unimpaired memory performance which may be due to 
recovery.13
However, while successful and widely used, the original 
RBMT suffered from a lack of sensitivity on some subtests,14 
as many subtests consisted of only a small number of items. 
The third edition of this test (RBMT-3) has overcome this 
problem by updating a number of stimuli, extending the 
number of trials in several subtests and by adding a new 
subtest.15 The RBMT-3 consists of a number of subtests, each 
of which addresses an important aspect of everyday memory 
function. For instance, patients have to remember a route, a 
short story or a message, must recall photographs of people, 
and have to remember to retrieve a personal belonging at the 
end of the examination. Also, orientation is tested and a newly 
developed puzzle subtest is included, in which participants 
have to relay puzzle pieces in a specific order. Thus, the 
RBMT-3 assesses verbal and nonverbal episodic memory, 
spatial memory, and aspects of prospective memory, and 
procedural memory. In several subtests, memory is tested 
both immediately after stimulus presentation and after a 
filled delay. The RBMT-3 has been examined in relatively 
small samples of patients with traumatic brain injury, 
stroke, encephalitis and neurodegenerative diseases (eg, 
Alzheimer’s disease).15 To date, however, no studies have 
been published using the RBMT-3 in patients with alcohol-
related cognitive deficits, while the original RBMT – despite 
its limitations – is still being used clinically. The present 
study examines the memory profile of amnesic patients 
with alcoholic Korsakoff’s syndrome using the RBMT-3 as a 
supposedly ecologically valid memory test battery, comparing 
their performance to non-Korsakoff chronic alcoholics (with 
mild cognitive impairments) and healthy controls.
Material and methods
Study design and participants
We have performed a case-control study using a convenience 
sample of patients with alcohol-abuse disorder that were 
diagnosed with Korsakoff ’s syndrome or had less severe 
memory deficits, as well as matched healthy controls. 
Recruited patients were inpatients of the Korsakoff clinic 
of Vincent van Gogh Institute for Psychiatry in Venray, the 
Netherlands. The Korsakoff patients fulfilled the DSM-
IV-TR criteria for alcohol-induced persisting amnestic 
disorder (DSM-IV-TR code 291.1), that is, a memory deficit 
had to be present that results in severe deficits in social 
functioning, in the absence of delirium or dementia, with 
a history of alcohol-abuse disorder. In addition, the criteria 
for alcoholic Korsakoff’s syndrome1 had to be met: evidence 
for a history of Wernicke encephalopathy, confabulation 
behavior and evidence for malnutrition or thiamine deficit. 
The patients with cognitive impairment and a history of 
chronic alcoholism (DSM-IV-TR Alcohol Dependence, 
DSM-IV-TR code 303.90) and fulfilled the DSM-IV-TR 
criteria for cognitive disorder not otherwise specified (DSM-
IV-TR code 294.9). All diagnoses were supported by medical 
history, psychiatric assessment, neuropsychological testing 
covering all major cognitive domains and neuroradiological 
findings, and all patients had been abstinent from alcohol for 
at least six weeks. None of the patients had any evidence for 
brain abnormalities that could account for their condition 
apart from atrophy or white-matter lesions associated 
with the chronic alcohol abuse. None of the participants 
fulfilled the proposed criteria for alcohol-related dementia,16 
and none of the participants had any hearing problems, 
language or communication deficits, or visual agnosia that 
could confound the performance on memory tests.
Healthy participants were recruited from the clinic’s 
staff, databases of healthy volunteers, and the network 
of the researchers. Exclusion criteria for controls were a 
psychiatric or neurologic history or subjective memory 
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complaints (self-report). Education level was assessed using 
7 categories in accordance with the Dutch educational system 
(1 = less than primary school; 7 = university degree). The 
Dutch version of the National Adult reading Task (NART) was 
administered to estimate verbal intelligence level (IQ).17
Materials
An authorized Dutch translation of the RBMT-3 was 
constructed to be equivalent to the previously published UK 
version of this test.15 Test items and test instructions were 
translated into Dutch and back translated into British English 
by native speakers. Differences in phrasing or meaning 
were resolved by discussion, resulting in a Dutch-language 
research version of the RBMT-3 that was used in the current 
study. The RBMT-3 consists of ten subtests (maximum 
score between brackets): Names (remembering the first and 
second names of two portrait photos; max = 8), Belongings 
(remembering to ask for two personal belongings at the end 
of the test session; max = 8), Appointments (asking two 
questions when an alarm rings 25 minutes later; max = 4), 
Picture Recognition (delayed recognition of line drawings; 
max = 15), Story (immediate and delayed recall of a short 
news story; max = 2 × 21), Faces (delayed recognition 
of photographs of faces; max = 15), Route (immediate 
and delayed recall of a short route in the examination 
room; max = 2 × 13), Message (immediate and delayed 
remembering to pick up an envelope and book; max = 2 × 6), 
Orientation and Date (orientation to person, place and time; 
max = 14), and Novel Task (immediate and delayed recall of 
puzzle pieces laid in a specific order within a template; max 
for three immediate trials = 51; max for delayed recall = 17). 
Administration of the RBMT-3 was performed in accordance 
with the test’s manual by trained neuropsychologists or 
research assistants and took approximately 30 minutes. 
In addition to the raw scores on the subtests, the Global 
Memory Index (GMI) was computed as an overall memory 
performance measure.
Analysis
Multivariate analyses of variance (General Linear Model) 
were performed using the performance on the individual 
subtests of the RBMT-3 for the three groups. Bonferroni-
corrected post-hoc analyses were performed to compare 
the specific groups (KS-CON, ALC-CON and KS-ALC), 
all post-hoc P-values reported are SPSS-adjusted P-values, 
and effect sizes (Cohen’s d) were computed. Additionally, 
receiver operating characteristic (ROC) analyses were 
performed on the GMI to determine the test’s diagnostic 
accuracy, comparing the KS and the ALC group and the 
ALC and CON groups. Cut-off scores for the GMI were 
determined that had good sensitivity ($0.8) and adequate 
specificity ($0.6).18 All analyses were performed using 
IBM SPSS Statistics Version 19. Alpha was set at 0.05 for 
all analyses.
Results
A total of 151 participants enrolled in this study, consisting 
of 49 patients with Korsakoff’s syndrome (KS), 49 patients 
with cognitive impairment and a history of chronic 
alcoholism (ALC), and 53 healthy controls (CON). 
Table 1 shows the demographic variables for the three groups 
of participants. The groups did not differ with respect to age 
(F[2,148] = 0.2), but differed with respect to education level 
(χ2[2] = 9.6, P = 0.008) and IQ (F[2,138] = 3.4, P = 0.04). 
The healthy controls had on average a higher education 
level than the KS patients (Mann–Whitney U = 979.5, 
Z = 2.6, P = 0.011) and the ALC group (U = 1032.5, Z = 2.2, 
P = 0.035), although in all three groups most participants had 
an average education level (categories 4 and 5). Bonferroni-
corrected post-hoc tests comparing the KS, ALC and CON 
groups directly did not reveal significant IQ differences (all 
P-values . 0.05). The groups differed with respect to sex 
distribution (χ2[2] = 7.9, P = 0.02), with fewer women KS 
and ALC patients compared to the healthy control group 
(U = 907.5, Z = 2.3, 0 = 0.021; U = 820.5, Z = 2.9, P = 0.003 
respectively).
Table 2 shows the results of the individual RBMT-3 subtests 
for the three groups. GLM analysis taking all subtests 
together demonstrated an overall main effect of Group 
(F[28,272] = 7.4, P , 0.0005). Subsequent multivariate GLM 
analyses on the individual subtests demonstrated an overall 
Group effect on all individual subtests (all F-values . 10.7, 
all P-values , 0.001). Post-hoc analyses comparing the 
patient groups with the controls, demonstrated a significant 
worse performance than controls on all subtests for the KS 
group (all P-values , 0.0005). The ALC group performed 
Table 1 Demographic variables for the Korsakoff patients 
(KS), the cognitively impaired alcoholics (ALC) and the healthy 
controls (CON)
KS ALC CON
Age (years; mean ± standard 
deviation)
55.6 (6.4) 55.0 (6.7) 54.9 (7.2)
Education level (mode + [range]) 4 (2–6) 4 (1–7) 5 (3–7)
NART-IQ (mean ± standard 
deviation)
90.3 (14.0) 90.9 (16.8) 97.2 (10.4)
Sex (male: female) 37:12 35:14 27:26
Abbreviation: NART, National Adult Reading Test.




Validity of the RBMT-3
Neuropsychiatric Disease and Treatment 2013:9
worse than controls on most subtests (all P-values , 0.02), 
but not on the subtests Picture Recognition, Story Recall – 
Delayed, Messages – Immediate, and Orientation, on which 
the performance did not differ significantly from controls. 
Directly comparing both patient groups showed a worse 
performance in the KS group compared to the ALC group 
on most subtests (all P-values , 0.001), except on the 
subtest Story Recall – Immediate on which no statistically 
significant difference was found (P = 0.10). With respect to 
effect sizes, large effects were found on all subtests, with 
the largest differences between the KS and CON group after 
delayed testing on Picture Recognition, Face Recognition, 
Route Recall, Messages, and the Novel Task, as well as on 
the subtests Belongings, Appointments and Orientation. 
Adjusting the analyses by including education level as a 
covariate did not alter the results (data not shown).
ROC analyses revealed that the RBMT-3 GMI had a 
statistically significant diagnostic accuracy in distinguishing 
KS patients from ALC patients (AUC = 0.85; 95% CI 
0.78–0.93; P , 0.0005). A cut-off score of GMI , 67.5 
had a sensitivity of 0.80 and a specificity of 0.69. The GMI 
could also distinguish ALC patients from healthy controls 
(AUC = 0.83; 95% CI 0.75–0.91; P , 0.0005). A GMI cut-off 
of 87.5 had a sensitivity of 0.80 and a specificity of 0.62.
Discussion
Aim of the present study was to examine whether the RBMT-3 
can be used to demonstrate alcohol-related memory deficits, 
and whether it is able to distinguish patients with KS from 
patients with more subtle alcohol-related memory deficits, 
and the latter from healthy controls. Our findings clearly show 
that both patients with KS and non-Korsakoff-alcoholics with 
cognitive deficits perform worse than matched controls on the 
RBMT-3. Looking at the pattern of impairments, largest effect 
sizes were found on tests of delayed recall, orientation, as well 
as cued and uncued prospective memory in the KS patients. 
This is in agreement with the presumed neural substrate of 
Korsakoff’s syndrome, that is, diencephalic lesions in the 
mammillary bodies and the thalamus.19 Also, some studies 
have reported hippocampal atrophy in KS patients.20,21 As a 
result, long-term storage of new information is hampered by 
a deficit in consolidation,22 which strongly relies on medial-
temporal lobe and diencephalic structures.2 Looking at the type 
of task that is tested after a delay, recognition tasks such as Face 
Recognition or Picture Recognition do not improve the memory 
performance, which also points towards a consolidation deficit 
rather than impaired retrieval, as in the latter recognition 
performance is expected to improve substantially.23 The 
deficit in delayed memory (“rapid forgetting”) has also 
been directly associated with lesions of KS patients in the 
diencephalon and hippocampus.21 Deficits on Route Recall 
and Messages in KS patients may be related to an impaired 
memory for contextual information, notably spatial memory 
and object-context integration.2 The impaired performance 
on the Novel Task may partly be due to a deficit in motor or 
procedural learning. While implicit learning in KS has been 
Table 2 Performance (mean number of correct items) on the RBMT-3 subtests for the Korsakoff patients (KS), the cognitively 
impaired alcoholics (ALC) and the healthy controls (CON)






Mean SD d Mean SD d Mean SD
Names 2.27 2.32 −1.81 3.98 2.59 −0.89 5.66 1.88
Belongings 4.24 1.92 −2.21 5.90 2.10 −0.82 6.87 1.19
Appointments 0.94 1.05 −2.46 2.31 1.40 −0.99 3.23 0.93
Picture Recognition – delayed 12.16 2.78 −4.03 14.08 1.30 −0.93 14.66 0.62
Story Recall – immediate 3.74 2.42 −0.92 4.91 2.79 −0.51 6.37 2.85
Story Recall – delayed 1.56 2.25 −1.39 4.02 2.92 −0.45 5.19 2.61
Face Recognition – delayed 8.86 3.27 −3.57 11.27 2.48 −1.64 13.32 1.25
Route Recall – immediate 6.20 2.42 −1.70 8.27 2.60 −0.90 10.58 2.58
Route Recall – delayed 4.78 2.58 −2.38 7.80 2.87 −1.20 10.89 2.57
Messages – immediate 4.57 1.67 −1.32 5.29 0.91 −0.44 5.64 0.81
Messages – delayed 2.94 1.91 −2.55 4.69 1.40 −0.81 5.51 1.01
Orientation and date 8.76 2.85 −2.97 11.66 1.44 −0.59 12.38 1.22
Novel Task – immediate 18.92 10.45 −1.95 27.92 10.79 −0.93 36.19 8.86
Novel Task – delayed 5.47 3.95 −2.67 11.31 4.81 −0.81 13.85 3.14
GMI 61.16 8.54 −2.63 76.00 11.96 −1.39 92.58 11.94
Abbreviations: RBMT-3, Rivermead Behavioural Memory Test – Third Edition; GMI, Global Memory Index; d, Cohen’s d, comparing patients with the controls; SD, 
standard deviation.
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shown to be preserved (eg, on visuoperceptual tasks or simple 
motor learning),24,25 impaired performance on more complex 
procedural tasks, such as spatial pattern learning or a Tower 
paradigm, have been demonstrated in KS patients.24,26 Also, 
performance on the Novel Task may rely on non-procedural 
processes, such as spatial working memory (in the immediate 
test) and visuospatial episodic recall after delayed testing. 
Finally, prospective memory deficits in KS patients have been 
linked to prefrontal dysfunction,27 or may be explained by the 
general inability to encode and consolidate information over 
longer periods of time, although studies are lacking examining 
prospective memory in more detail in KS patients.
With respect to the non-Korsakoff alcoholics, effect 
sizes in the ALC group compared to the controls were 
smaller than in the KS group, and the performance did not 
differ from the healthy participants on all subtests. That is, 
orientation, memory for pictures, messages and prose recall 
were at control level. KS patients also performed worse 
than the ALC group on all but one RBMT-3 subtest. These 
results are in agreement with a previous study that also 
demonstrated unimpaired performance on the original RBMT 
subtest Story Recall in chronic alcoholics.28 In contrast, 
a study in long-abstinent chronic alcoholics reported an 
unimpaired performance on all original RBMT subtests.13 
The discrepancy with our study in which we show memory 
deficits on many RBMT-3 subtests in non-Korsakoff chronic 
alcoholics could be due to recovery, as their patients have 
been abstinent over 6 months, while the chronic alcoholics 
in the present study sample had been abstinent for 6 weeks. 
Moreover, a recruitment bias may be present, as the non-
Korsakoff chronic alcoholics in our clinic are being referred 
because of possible cognitive deficits. Alternatively, these 
apparently mixed results may also be the result of the relative 
insensitivity of the original RBMT. That is, previously29 
we showed by directly comparing the performance on the 
RBMT and the RBMT-3 that the latter is more sensitive in 
detecting alcohol-related memory deficits and that ceiling 
effects are present on some subtests. The effect sizes of the 
ALC group in the present study were in the moderate to large 
range,30 indicating that while the memory impairments on 
the RBMT-3 are not as profound as in KS, they are clinically 
relevant and may hamper everyday functioning.
The Global Memory Index of the RBMT-3 showed good 
diagnostic accuracy to distinguish KS patients from milder 
forms of memory deficits after alcohol-abuse disorder, and 
the latter group from healthy controls. However, these results 
should be interpreted with some caution, as there may be a risk 
of circularity here. That is, although the diagnoses were made 
based on medical history, radiological findings, and extensive 
cognitive testing, also in non-memory domains and using 
other memory tests such as the California Verbal Learning 
Test, having ‘amnesia’ is part of the diagnostic criteria for 
KS which has to be diagnosed using neuropsychological 
tests. Still, the presented cut-off values shown here may be 
useful for clinicians working with patients with alcohol-abuse 
disorder that are suspected of having memory deficits.
While the Rivermead Behavioral Memory tests batteries 
have been developed to assess everyday memory performance 
presumably adopting a more ecologically valid approach, the 
ecological validity of this test battery has also been criticized. 
For example, Koltai et al31 compared the performance of a 
group of patients that had been exposed to neurotoxic agents 
on the revised Wechsler Memory Scale (WMS-R, a ‘non-
ecological’ memory battery) and the RBMT, and could 
neither demonstrate significant differences between the two 
tests, nor establish any incremental value of administering a 
combination of the two memory batteries. Others32 showed that 
RBMT total score could not significantly predict functional 
status in patients with multiple sclerosis (MS). In that study, 
both delayed RBMT Story Recall and delayed recall of the 
CVLT predicted functional status at subtest level, questioning 
the added value of ecologically valid memory tests. However, 
in that study some RBMT subtests were not administered 
because of ceiling effects in MS patients, which may also 
explain this lack of statistical significance. With respect to the 
RBMT-3, only modest correlations have been found between 
the GMI and self- and proxy-rated versions of a rating scale 
for everyday memory problems.15 However, no studies have 
yet been performed in people with alcohol-related cognitive 
disorders or in any other patient sample using the RBMT-3 
that specifically examine the test’s predictive validity for other 
ecological outcome measures, such as return to work or ability 
to live independently in people with alcohol-related cognitive 
disorders or any other patient sample. Finally, it should be 
noted that not all aspects of memory can be examined using 
the RBMT-3. That is, the test does not include subtests 
assessing working memory or semantic memory, which would 
be relevant as deficits in these memory functions have also 
been demonstrated in Korsakoff patients.22,33,34.
Our results showing memory deficits in patients with 
alcohol-abuse disorder also emphasize concurrent findings 
that treatment in patients with alcohol-abuse disorder 
should not only be limited to the addiction itself. That is, the 
cognitive deficits should be taken into account as well,35 for 
example by incorporating strategy or other compensatory 
trainings based on cognitive rehabilitation principles. 
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Moreover, the presence of severe cognitive deficits also 
requires adjustment of the available treatment programs in 
addiction care.36 For example, group psychotherapy sessions 
may be less effective in cognitively-impaired patients, as a 
lot of information is being shared. Also, cognitive deficits 
affect the applicability of cognitive-behavioral therapy, which 
relies on self-reflection, sharing of conceptualizations, and 
explicitly remembering stressful situations. Finally, a detailed 
profile of everyday memory (dys)function provides specific 
information about an individual patient that can guide care 
professionals and optimize clinical management.
Conclusion
Our present results show that the RBMT-3 seems to have 
clinical relevance for the assessment of severe memory 
deficits in KS patients on the one hand and milder memory 
impairments associated with chronic alcohol abuse on the 
other. Especially the performance on subtests relying on 
orientation, contextual memory and delayed testing are 
impaired in KS patients, related to the presumed underlying 
dysfunction in hippocampal-diencephalic brain regions. The 
deficits in the ALC group are less severe, and on some sub-
tests even at control level. Our findings stress that cognitive 
impairment should on the one hand also be considered in 
the treatment of patients with alcohol-use disorder (eg, using 
cognitive rehabilitation), and available addiction therapies 
should be adjusted for patients with limitations in cognitive 
processing capacities. Future studies should examine the 
ecological validity (ie, predictive value) of the RBMT-3 for 
everyday function in these patients. In addition, the validity 
of changes in performance on the RBMT-3 parallel version 
as an outcome measure of, for example, cognitive rehabilita-
tion or spontaneous recovery in non-Korsakoff alcoholics, 
remains to be determined.
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